Skip to main content
Equibles

Allianz Asset Management GmbH

Position in BMY — Bristol Myers Squibb Co

CIK 1535323 MUNICH, 2M
Back to BMY Full portfolio

Position in BMY

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$417,263,749
+$120,842,629 QoQ
Shares Held
6,879,864
+25.2% QoQ
Ownership
0.337%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 67.22204101708988.ToString("F0")% Shared 0.ToString("F0")% None 32.77795898291013.ToString("F0")%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Derivatives in BMY

reported options exposure · as of Mar 31, 2026
CallValue
$5,282,615
CallShares
87,100
PutValue
$6,823,125
PutShares
112,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Allianz Asset Management GmbH holds $5,105,423,958 across 13 Drug Manufacturers - General names. BMY ranks #6 (8.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JNJ
Johnson & Johnson
 5,690,502 $1,390,986,307
2 AZN
Astrazeneca PLC
 6,529,961 $1,287,838,906
3 MRK
Merck & Co., Inc.
 3,964,890 $476,936,615
4 LLY
ELI LILLY & Co
 504,764 $464,266,781
5 GILD
Gilead Sciences, Inc.
 3,094,227 $431,242,416
6 BMY
Bristol Myers Squibb Co
This page 		6,879,864 $417,263,749
7 ABBV
AbbVie Inc.
 1,393,938 $303,167,574
8 PFE
Pfizer Inc
 5,490,142 $154,163,186

All Filings in BMY

Export CSV
42 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $417,263,749 6,879,864
2026-03-31 $5,282,615 87,100
2026-03-31 $6,823,125 112,500
2025-12-31 $296,421,120 5,495,386
2025-12-31 $5,226,786 96,900
2025-12-31 $4,185,744 77,600
2025-09-30 $3,373,480 74,800
2025-09-30 $2,575,210 57,100
2025-09-30 $234,382,534 5,196,952
2025-06-30 $4,068,891 87,900
2025-06-30 $6,216,747 134,300
2025-06-30 $209,084,336 4,516,836
2025-03-31 $4,293,696 70,400
2025-03-31 $199,504,813 3,271,107
2025-03-31 $3,147,084 51,600
2024-12-31 $193,574,563 3,422,464
2024-12-31 $3,535,000 62,500
2024-12-31 $1,397,032 24,700
2024-09-30 $3,156,140 61,000
2024-09-30 $78,758,470 1,522,197
2024-09-30 $5,080,868 98,200
2024-06-30 $2,192,784 52,800
2024-06-30 $61,599,994 1,483,265
2024-06-30 $1,686,118 40,600
2024-03-31 $103,119,806 1,901,527
2024-03-31 $189,805 3,500
2024-03-31 $119,306 2,200
2023-12-31 $88,470,443 1,724,234
2023-09-30 $87,845,859 1,513,540
2023-06-30 $111,842,984 1,748,913
2023-03-31 $136,705,448 1,972,377
2022-12-31 $135,836,850 1,887,934
2022-09-30 $123,237,072 1,733,536
2022-06-30 $189,601,874 2,462,362
2022-03-31 $96,878,966 1,326,564
2021-09-30 $129,755,844 2,192,933
2021-06-30 $149,133,819 2,231,874
2021-03-31 $133,138,580 2,108,959
2020-12-31 $274,689,619 4,428,335
2020-09-30 $270,822,979 4,492,005
2020-06-30 $405,701,947 6,899,693
2020-03-31 $336,947,407 6,044,984

Report a Problem

Category
Description
Email (optional, for follow-up)